SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-23-013837
Filing Date
2023-11-07
Accepted
2023-11-06 18:36:25
Documents
14
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 12120
2 ARRANGEMENT AGREEMENT fsd_ex991.htm EX-99.1 313891
3 AGREEMENT OF PURCHASE fsd_ex992.htm EX-99.2 5669
4 NOTICE OF ABRIDGMENT fsd_ex993.htm EX-99.3 948
5 fsd_ex993img1.jpg GRAPHIC 109963
6 fsd_ex992img9.jpg GRAPHIC 277391
7 fsd_ex992img8.jpg GRAPHIC 301445
8 fsd_ex992img7.jpg GRAPHIC 305953
9 fsd_ex992img6.jpg GRAPHIC 270590
10 fsd_ex992img5.jpg GRAPHIC 253685
11 fsd_ex992img4.jpg GRAPHIC 327581
12 fsd_ex992img3.jpg GRAPHIC 389444
13 fsd_ex992img2.jpg GRAPHIC 257295
14 fsd_ex992img1.jpg GRAPHIC 209748
  Complete submission text file 0001654954-23-013837.txt   4057569
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 231381115
SIC: 2834 Pharmaceutical Preparations